Tag Archives: TGTX

TG Therapeutics, Inc. (TGTX)

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for b-cell malignancies and autoimmune diseases. The Company is developing over two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody that targets a specific epitope on the CD20 antigen found on mature....More>>>

News about TGTX

Benzinga's Option Alert Recap From October 12
Related GM Auto Stock Roundup: September China Sales Up, Autonomous & EV Move On, Tesla In Focus GM Confirms Production Cutback, Temporary Shutdown In Detroit Plant Why the Market Is Rewarding Gene...Read More>>>

Watch These 8 Huge Call Purchases In Friday Trade
...

U.S. stocks set to start week lower in shadow of U.K. terror attacks
U.S. stock futures slipped Monday, as investors tried to look past a fresh terror attack in the U.K. to potentially market-moving events later in the week, and as oil prices rose on a rift among Gulf states. This week will deliver testimony by Federa...Read More>>>

25 Stocks Moving In Monday's Pre-Market Session
Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ:...Read More>>>

A Profitable And Growing Microcap Investment Bank Focused On The Biotech Sector
I first wrote about National Holdings Corp. (NASDAQ:NHLD) in this 3/10/2017 article. NHLD had just reported blowout fiscal Q1 earnings and I predicted "higher growth and profitability" for 2017. NHLD certainly delivered in fiscal Q2. They posted very...Read More>>>